Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Deficit [Member]
Balance (in shares) at Dec. 31, 2023		9,454,233
Balance at Dec. 31, 2023	$ (14,544,546)	$ 94,542	$ 124,451,067	$ (48,308)	$ (139,041,846)
Stock-based compensation	670,625	$ 0	670,625	0	0
Restricted shares/stock activity (in shares)		144,500
Restricted shares/stock activity	0	$ 1,445	(1,445)	0	0
Common stock issuance (in shares)		11,022
Common stock issuance	227,598	$ 110	227,488	0	0
Cost of common stock issuance	(6,257)	$ 0	(6,257)	0	0
Stock issued for convertible debt/note interest payment (in shares)		6,329
Stock issued for convertible debt/note interest payment	99,998	$ 63	99,935	0	0
Net Income (Loss)	(20,497,239)	$ 0	0	0	(20,497,239)
Balance (in shares) at Mar. 31, 2024		9,616,084
Balance at Mar. 31, 2024	(34,049,820)	$ 96,160	125,441,413	(48,308)	(159,539,085)
Balance (in shares) at Dec. 31, 2024		12,230,959
Balance at Dec. 31, 2024	1,272,645	$ 122,308	178,270,782	(48,308)	(177,072,137)
Stock-based compensation	532,621	$ 0	532,621	0	0
Restricted shares/stock activity (in shares)		285,700
Restricted shares/stock activity	0	$ 2,857	(2,857)	0	0
Common stock issuance (in shares)		76,703
Common stock issuance	821,512	$ 767	820,745	0	0
Cost of common stock issuance	(22,590)	$ 0	(22,590)	0
Shares repurchased for tax withholdings on share-based awards (in shares)		(60,763)
Shares repurchased for tax withholdings on share-based awards	(659,279)	$ (608)	(658,671)	0	0
Stock issued for convertible debt/note interest payment (in shares)		9,363
Stock issued for convertible debt/note interest payment	99,995	$ 94	99,901	0	0
Net Income (Loss)	(22,548,325)	$ 0	0	0	(22,548,325)
Balance (in shares) at Mar. 31, 2025		12,541,962
Balance at Mar. 31, 2025	$ (20,503,421)	$ 125,418	$ 179,039,931	$ (48,308)	$ (199,620,462)